Authors | Kai-Lung Chen, Chia-Chi Lin, Yung-Tsu Cho, Che-Wen Yang, Yi-Shuan Sheen, Hsiao-En Tsai, Chia-Yu Chu |
Journal | JAMA dermatology
(JAMA Dermatol)
Vol. 152
Issue 3
Pg. 340-2
(Mar 2016)
ISSN: 2168-6084 [Electronic] United States |
PMID | 26649681
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Quinazolines
- Afatinib
- Erlotinib Hydrochloride
- Gefitinib
|
Topics |
- Acneiform Eruptions
(chemically induced, epidemiology)
- Afatinib
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Carcinoma, Non-Small-Cell Lung
(drug therapy)
- Cohort Studies
- Compassionate Use Trials
- Cross-Sectional Studies
- Drug Eruptions
(diagnosis, etiology)
- Erlotinib Hydrochloride
(adverse effects, therapeutic use)
- Gefitinib
- Humans
- Ichthyosis
(chemically induced, epidemiology)
- Lung Neoplasms
(drug therapy)
- Paronychia
(chemically induced, epidemiology)
- Pruritus
(chemically induced, epidemiology)
- Quinazolines
(adverse effects, therapeutic use)
- Retrospective Studies
|